Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment

Delafloxacin is a novel anionic fluoroquinolone with robust activity against Gram‐positive, Gram‐negative, atypical, and anaerobic bacteria, including methicillin‐resistant S aureus. Delafloxacin is currently being studied for the treatment of acute bacterial skin and skin structure infections and c...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Pharmacol
Glavni autori: Hoover, Randall, Marbury, Thomas C., Preston, Richard A., Quintas, Megan, Lawrence, Laura E., Paulson, Susan K., Luke, David R., Cammarata, Sue K.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Special Populations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5324641/
https://ncbi.nlm.nih.gov/pubmed/27570245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.817
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items